BioGeneration Ventures Fund III Secures EUR 66m, exceed EUR 50m target
Posted on June 27, 2017 in BioGeneration Ventures, BioGeneration Ventures highlight, Highlights
Naarden, The Netherlands, 27 June 2017 – BioGeneration Ventures (BGV), the early stage Life Sciences Venture Capital firm with funds focussed on European biotechnology companies, announces today an investment by the European Investment Fund (EIF) and other new investors in BGV III, taking the total capital commitments to EUR 66m, out of a maximum EUR 75m. Please read full press release HERE.
